Gamma Butyrolactone 99 10LT
Gamma Butyrolactone 99 10LT
Gamma Butyrolactone 99 10LT
1. Identification
Product Name y-Butyrolactone
Company
Fisher Scientific Company Acros Organics
One Reagent Lane One Reagent Lane
Fair Lawn, NJ 07410 Fair Lawn, NJ 07410
Tel: (201) 796-7100
Emergency Telephone Number For information US call: 001-800-ACROS-01 / Europe call: +32 14 57 52 11
Emergency Number US:001-201-796-7100 / Europe: +32 14 57 52 99
CHEMTREC Tel. No.US:001-800-424-9300 / Europe:001-703-527-3887
2. Hazard(s) identification
Classification
This chemical is considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200)
Label Elements
Signal Word
Danger
Hazard Statements
______________________________________________________________________________________________
Page 1 / 7
y-Butyrolactone Revision Date 24-Dec-2021
______________________________________________________________________________________________
Harmful if swallowed
Causes serious eye damage
May cause drowsiness or dizziness
Precautionary Statements
Prevention
Wash face, hands and any exposed skin thoroughly after handling
Do not eat, drink or smoke when using this product
Wear protective gloves/protective clothing/eye protection/face protection
Avoid breathing dust/fume/gas/mist/vapors/spray
Use only outdoors or in a well-ventilated area
Inhalation
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
Call a POISON CENTER or doctor/physician if you feel unwell
Eyes
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing
Immediately call a POISON CENTER or doctor/physician
Ingestion
IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell
Rinse mouth
Storage
Store in a well-ventilated place. Keep container tightly closed
Store locked up
Disposal
Dispose of contents/container to an approved waste disposal plant
Hazards not otherwise classified (HNOC)
None identified
3. Composition/Information on Ingredients
Component CAS No Weight %
.gamma.-Butyrolactone 96-48-0 >95
4. First-aid measures
Eye Contact Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Get
medical attention.
Skin Contact Wash off immediately with plenty of water for at least 15 minutes. Get medical attention
immediately if symptoms occur.
Inhalation Remove to fresh air. Do not use mouth-to-mouth method if victim ingested or inhaled the
substance; give artificial respiration with the aid of a pocket mask equipped with a one-way
valve or other proper respiratory medical device. Get medical attention. If not breathing,
give artificial respiration.
Ingestion Do NOT induce vomiting. Call a physician or poison control center immediately.
Most important symptoms and Causes eye burns. Causes severe eye damage.
______________________________________________________________________________________________
Page 2 / 7
y-Butyrolactone Revision Date 24-Dec-2021
______________________________________________________________________________________________
effects
Notes to Physician Treat symptomatically
5. Fire-fighting measures
Suitable Extinguishing Media Water spray, carbon dioxide (CO2), dry chemical, alcohol-resistant foam.
Explosion Limits
Upper 16 vol %
Lower 3.6 vol %
Sensitivity to Mechanical Impact No information available
Sensitivity to Static Discharge No information available
NFPA
Health Flammability Instability Physical hazards
2 1 1 N/A
Methods for Containment and Clean Soak up with inert absorbent material. Keep in suitable, closed containers for disposal.
Up
Storage. Keep containers tightly closed in a dry, cool and well-ventilated place. Incompatible
Materials. Strong oxidizing agents. Strong reducing agents. Strong acids.
Engineering Measures Ensure that eyewash stations and safety showers are close to the workstation location.
Ensure adequate ventilation, especially in confined areas.
______________________________________________________________________________________________
Page 3 / 7
y-Butyrolactone Revision Date 24-Dec-2021
______________________________________________________________________________________________
Eye/face Protection Wear appropriate protective eyeglasses or chemical safety goggles as described by
OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard
EN166.
Skin and body protection Wear appropriate protective gloves and clothing to prevent skin exposure.
Respiratory Protection Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if
exposure limits are exceeded or if irritation or other symptoms are experienced.
Hygiene Measures Handle in accordance with good industrial hygiene and safety practice.
Stability Hygroscopic.
Conditions to Avoid Incompatible products. Excess heat. Exposure to moist air or water.
Incompatible Materials Strong oxidizing agents, Strong reducing agents, Strong acids
______________________________________________________________________________________________
Page 4 / 7
y-Butyrolactone Revision Date 24-Dec-2021
______________________________________________________________________________________________
Product Information
Component Information
Component LD50 Oral LD50 Dermal LC50 Inhalation
.gamma.-Butyrolactone LD50 = 1540 mg/kg ( Rat ) LD50 > 5640 mg/kg ( Rabbit ) >2.68 mg/L ( Rat ) 4 h
Carcinogenicity The table below indicates whether each agency has listed any ingredient as a carcinogen.
Other Adverse Effects The toxicological properties have not been fully investigated.
Persistence and Degradability Miscible with water Persistence is unlikely based on information available.
Mobility . Will likely be mobile in the environment due to its water solubility.
______________________________________________________________________________________________
Page 5 / 7
y-Butyrolactone Revision Date 24-Dec-2021
______________________________________________________________________________________________
hazardous waste. Chemical waste generators must also consult local, regional, and
national hazardous waste regulations to ensure complete and accurate classification.
Legend:
TSCA US EPA (TSCA) - Toxic Substances Control Act, (40 CFR Part 710)
X - Listed
'-' - Not Listed
International Inventories
Canada (DSL/NDSL), Europe (EINECS/ELINCS/NLP), Philippines (PICCS), Japan (ENCS), Japan (ISHL), Australia (AICS), China (IECSC), Korea
(KECL).
Component CAS No DSL NDSL EINECS PICCS ENCS ISHL AICS IECSC KECL
.gamma.-Butyrolactone 96-48-0 X - 202-509-5 X X X X X KE-10674
California Proposition 65 This product does not contain any Proposition 65 chemicals.
______________________________________________________________________________________________
Page 6 / 7
y-Butyrolactone Revision Date 24-Dec-2021
______________________________________________________________________________________________
U.S. Department of Homeland This product does not contain any DHS chemicals.
Security
Safety, health and environmental regulations/legislation specific for the substance or mixture
Component CAS No Seveso III Directive Seveso III Directive Rotterdam Basel Convention
(2012/18/EC) - (2012/18/EC) - Convention (PIC) (Hazardous Waste)
Qualifying Quantities Qualifying Quantities
for Major Accident for Safety Report
Notification Requirements
.gamma.-Butyrolactone 96-48-0 Not applicable Not applicable Not applicable Not applicable
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the
date of its publication. The information given is designed only as a guidance for safe handling, use, processing, storage,
transportation, disposal and release and is not to be considered a warranty or quality specification. The information
relates only to the specific material designated and may not be valid for such material used in combination with any other
materials or in any process, unless specified in the text
End of SDS
______________________________________________________________________________________________
Page 7 / 7